Related references
Note: Only part of the references are listed.Expression of the osteonectin gene potentially controlled by multiple Cis- and trans-acting factors in cultured bone cells
Pedro Dominguez et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
Alena Gros et al.
CANCER RESEARCH (2008)
All in the Stroma: Cancer's Cosa Nostra
Jean Marx
SCIENCE (2008)
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus
Wison Mok et al.
CANCER RESEARCH (2007)
Oncolytic viruses in cancer therapy
Markus J. V. Vaha-Koskela et al.
CANCER LETTERS (2007)
Engineering targeted viral vectors for gene therapy
Reinhard Waehler et al.
NATURE REVIEWS GENETICS (2007)
SPARC enhances tumor stroma formation and prevents fibroblast activation
A. Chlenski et al.
ONCOGENE (2007)
Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes
Clare Selden et al.
JOURNAL OF GENE MEDICINE (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Cancer selective adenoviruses
Ramon Alemany
MOLECULAR ASPECTS OF MEDICINE (2007)
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of fibroblast heterogeneity in the tumor microenvironment
Hikaru Sugimoto et al.
CANCER BIOLOGY & THERAPY (2006)
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
Joo-Hang Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth
Maria V. Lopez et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts
R Gonzalez et al.
JOURNAL OF VIROLOGY (2006)
Oncolytic adenoviruses - selective retargeting to tumor cells
JM Mathis et al.
ONCOGENE (2005)
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases
P Sova et al.
MOLECULAR THERAPY (2004)
Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation
Q Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells
AA Rivera et al.
GENE THERAPY (2004)
Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA
DM Nettelbeck et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettes
P Martin-Duque et al.
HUMAN GENE THERAPY (2004)
Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer
M Yamamoto et al.
GASTROENTEROLOGY (2003)
Enhanced adenovirus infection of melanoma cells by fiber-modification - Incorporation of RGD peptide or Ad5/3 chimerism
AL Volk et al.
CANCER BIOLOGY & THERAPY (2003)
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions
N Sato et al.
ONCOGENE (2003)
Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells
J Briggs et al.
ONCOGENE (2002)
The DPE, a core promoter element for transcription by RNA polymerase II
JT Kadonaga
EXPERIMENTAL AND MOLECULAR MEDICINE (2002)
Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells
MJ Savontaus et al.
GENE THERAPY (2002)
Analysis of the gene expression of SPARC and its prognostic value for bladder cancer
M Yamanaka et al.
JOURNAL OF UROLOGY (2001)
SPARC expression in primary human renal cell carcinoma: Upregulation of SPARC in sarcomatoid renal carcinoma
N Sakai et al.
HUMAN PATHOLOGY (2001)
Induction of SPARC by VEGF in human vascular endothelial cells
Y Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury
AD Bradshaw et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The results of colorectal cancer treatment by p53 status - Treatment-specific overview
S Petersen et al.
DISEASES OF THE COLON & RECTUM (2001)
SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins
SA Rempel et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds
R Bilbao et al.
GENE THERAPY (2000)
Share Paper
